• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Sci Rep . Development of spiro-3-indolin-2-one containing compounds of antiproliferative and anti-SARS-CoV-2 properties

tetano

Editor, Senior Moderator
Sci Rep


. 2022 Aug 16;12(1):13880.
doi: 10.1038/s41598-022-17883-9.
Development of spiro-3-indolin-2-one containing compounds of antiproliferative and anti-SARS-CoV-2 properties


Nehmedo G Fawazy[SUP] 1 [/SUP], Siva S Panda[SUP] 2 [/SUP], Ahmed Mostafa[SUP] 3 [/SUP], Benson M Kariuki[SUP] 4 [/SUP], Mohamed S Bekheit[SUP] 1 [/SUP], Yassmin Moatasim[SUP] 3 [/SUP], Omnia Kutkat[SUP] 3 [/SUP], Walid Fayad[SUP] 5 [/SUP], May A El-Manawaty[SUP] 5 [/SUP], Ahmed A F Soliman[SUP] 5 [/SUP], Riham A El-Shiekh[SUP] 6 [/SUP], Aladdin M Srour[SUP] 7 [/SUP], Reham F Barghash[SUP] 1 [/SUP], Adel S Girgis[SUP] 8 [/SUP]



Affiliations

Abstract

A series of 1″-(alkylsulfonyl)-dispiro[indoline-3,2'-pyrrolidine-3',3″-piperidine]-2,4″-diones 6a‒o has been synthesized through regioselective multi-component azomethine dipolar cycloaddition reaction of 1-(alkylsulfonyl)-3,5-bis(ylidene)-piperidin-4-ones 3a‒h. X-ray diffraction studies (6b‒d,h) confirmed the structures. The majority of the synthesized analogs reveal promising antiproliferation properties against a variety of human cancer cell lines (MCF7, HCT116, A431 and PaCa2) with good selectivity index towards normal cell (RPE1). Some of the synthesized agents exhibit potent inhibitory properties against the tested cell lines with higher efficacies than the standard references (sunitinib and 5-fluorouracil). Compound 6m is the most potent. Multi-targeted inhibitory properties against EGFR and VEGFR-2 have been observed for the synthesized agents. Flow cytometry supports the antiproliferation properties and shows the tested agents as apoptosis and necrosis forming. Vero cell viral infection model demonstrates the anti-SARS-CoV-2 properties of the synthesized agents. Compound 6f is the most promising (about 3.3 and 4.8 times the potency of the standard references, chloroquine and hydroxychloroquine). QSAR models explain and support the observed biological properties.
 
Back
Top Bottom